Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease

Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease (ESRD) and is therefore a major burden on the healthcare system. Patients with DKD are highly susceptible to developing cardiovascular disease, which contributes to increased morbidity and mortality rates. While progr...

Full description

Bibliographic Details
Main Authors: Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Daiji Kawanami, Kazunori Utsunomiya, Rimei Nishimura
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/14/3393
id doaj-643b71ef95df413f88df68e0c3ce90b4
record_format Article
spelling doaj-643b71ef95df413f88df68e0c3ce90b42020-11-24T21:29:17ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-07-012014339310.3390/ijms20143393ijms20143393Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney DiseaseKeiichiro Matoba0Yusuke Takeda1Yosuke Nagai2Daiji Kawanami3Kazunori Utsunomiya4Rimei Nishimura5Division of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, JapanDivision of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, JapanDivision of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, JapanDepartment of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine, Fukuoka 814-0180, JapanCenter for Preventive Medicine, The Jikei University School of Medicine, Tokyo 105-8461, JapanDivision of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, JapanDiabetic kidney disease (DKD) remains the leading cause of end-stage renal disease (ESRD) and is therefore a major burden on the healthcare system. Patients with DKD are highly susceptible to developing cardiovascular disease, which contributes to increased morbidity and mortality rates. While progress has been made to inhibit the acceleration of DKD, current standards of care reduce but do not eliminate the risk of DKD. There is growing appreciation for the role of inflammation in modulating the process of DKD. The focus of this review is on providing an overview of the current status of knowledge regarding the pathologic roles of inflammation in the development of DKD. Finally, we summarize recent therapeutic advances to prevent DKD, with a focus on the anti-inflammatory effects of newly developed agents.https://www.mdpi.com/1422-0067/20/14/3393diabetic kidney diseasediabetic nephropathyinflammationsignaling cascade
collection DOAJ
language English
format Article
sources DOAJ
author Keiichiro Matoba
Yusuke Takeda
Yosuke Nagai
Daiji Kawanami
Kazunori Utsunomiya
Rimei Nishimura
spellingShingle Keiichiro Matoba
Yusuke Takeda
Yosuke Nagai
Daiji Kawanami
Kazunori Utsunomiya
Rimei Nishimura
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
International Journal of Molecular Sciences
diabetic kidney disease
diabetic nephropathy
inflammation
signaling cascade
author_facet Keiichiro Matoba
Yusuke Takeda
Yosuke Nagai
Daiji Kawanami
Kazunori Utsunomiya
Rimei Nishimura
author_sort Keiichiro Matoba
title Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
title_short Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
title_full Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
title_fullStr Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
title_full_unstemmed Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
title_sort unraveling the role of inflammation in the pathogenesis of diabetic kidney disease
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2019-07-01
description Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease (ESRD) and is therefore a major burden on the healthcare system. Patients with DKD are highly susceptible to developing cardiovascular disease, which contributes to increased morbidity and mortality rates. While progress has been made to inhibit the acceleration of DKD, current standards of care reduce but do not eliminate the risk of DKD. There is growing appreciation for the role of inflammation in modulating the process of DKD. The focus of this review is on providing an overview of the current status of knowledge regarding the pathologic roles of inflammation in the development of DKD. Finally, we summarize recent therapeutic advances to prevent DKD, with a focus on the anti-inflammatory effects of newly developed agents.
topic diabetic kidney disease
diabetic nephropathy
inflammation
signaling cascade
url https://www.mdpi.com/1422-0067/20/14/3393
work_keys_str_mv AT keiichiromatoba unravelingtheroleofinflammationinthepathogenesisofdiabetickidneydisease
AT yusuketakeda unravelingtheroleofinflammationinthepathogenesisofdiabetickidneydisease
AT yosukenagai unravelingtheroleofinflammationinthepathogenesisofdiabetickidneydisease
AT daijikawanami unravelingtheroleofinflammationinthepathogenesisofdiabetickidneydisease
AT kazunoriutsunomiya unravelingtheroleofinflammationinthepathogenesisofdiabetickidneydisease
AT rimeinishimura unravelingtheroleofinflammationinthepathogenesisofdiabetickidneydisease
_version_ 1725966376505442304